当院では在宅診療の患者さん、および外来でワクチン接種を行なっております（予約制）。
在宅患者さんの、ワクチン接種
- 在宅診療時に、スタッフへご連絡
- ワクチン問診票をお渡ししますので、記入してご準備下さい
- ワクチンを発注
- 往診時、ワクチン接種（料金は引き落とし、もしくは振込となります）
外来患者さんの、ワクチン接種
- お電話にて接種希望のワクチン、外来に来られる日をお伝え下さい（完全予約制）
- 当日、問診票をご記入いただき、ワクチン接種となります
- 料金は現地で、キャッシュレス決済にて承ります（現金は取り扱いがありませんので、ご注意下さい）
帯状疱疹ワクチンの、早期接種も可
帯状疱疹は、身近でありながら危険な疾患です。
帯状疱疹後の神経痛に、数年もしくは半永久的に悩まれる方もおり、顔面神経に発症した場合、難聴・兎眼（目を閉じる事ができず、目が赤くなってしまう事）を伴う「ラムゼイハント症候群」を発症してしまう事もあります。
また近年では帯状疱疹ワクチン接種による、認知症リスクの減少効果についても一定のエビデンスを集めており、有効性が示唆されております。
帯状疱疹ワクチンがなぜ認知症リスクを減じるかについては、VZVに対する抑制作用だけではなく、ワクチンがVZVに対する特異的な免疫以外に、より広範な免疫システム（自然免疫のトレーニング効果や異種免疫など）を調節し、それが認知症予防に繋がっているのではないかとしています。ただし、これを裏付けるにはまだ基礎研究も不足している状況にあるのも事実です。
当院としては、予防という点において、リスクやコストに対してリターンが大きい可能性が高いと判断しております。行政の補助の対象となる６５歳を待たず、ワクチン接種する事も可能としています。
行政からの補助がございませんので、ご注意下さい。
ワクチン費用（税別）
| インフルエンザワクチン（在宅診療時の接種） | 4,000円/人
※65歳以上（静岡市在住）の方は助成金による補助があるため、自己負担1,650円に減額されます。詳しくはお尋ね下さい。 |
| インフルエンザワクチン（産業医顧問先への接種） | 5,000円/人 |
| 帯状疱疹ワクチン（不活化ワクチン、シングリックス） | 20,000円/回
※2回接種のワクチンですので、2回合計40,000円です。 |
参考文献
[1] Chen J, Abrahamson PE, Ke Y, et al. A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific. Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. https://pubmed.ncbi.nlm.nih.gov/38767209/ [2] Kawai K, Yawn BP, Wollan P, et al. Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin Infect Dis. 2016 Jul 15;63(2):221-6. doi: 10.1093/cid/ciw296. https://pubmed.ncbi.nlm.nih.gov/27161774/ [3] Li Y, An Z, Yin D, et al. Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey. PLoS One. 2016 Apr 7;11(4):e0152660. doi: 10.1371/journal.pone.0152660. https://pubmed.ncbi.nlm.nih.gov/27055179/ [4] Ultsch B, Siedler A, Rieck T, et al. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011 Jun 16;11:173. doi: 10.1186/1471-2334-11-173. https://pubmed.ncbi.nlm.nih.gov/21679419/ [5] Tricco AC, Zarin W, Cardoso R, et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ. 2018 Oct 25;363:k4029. doi: 10.1136/bmj.k4029. https://pubmed.ncbi.nlm.nih.gov/30361202/ [6] Solito E, Sastre M. Microglia function in Alzheimer’s disease. Front Pharmacol. 2012 Feb 10;3:14. doi: 10.3389/fphar.2012.00014. https://pubmed.ncbi.nlm.nih.gov/22363284/ [7] Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007 Feb;7(2):161-7. doi: 10.1038/nri2015. https://pubmed.ncbi.nlm.nih.gov/17220915/ [8] Pereira BI, Akbar AN. Convergence of Innate and Adaptive Immunity during Human Aging. Front Immunol. 2016 Nov 4;7:445. doi: 10.3389/fimmu.2016.00445. https://pubmed.ncbi.nlm.nih.gov/27867379/ [9] Tsai MC, Cheng WL, Sheu JJ, et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS One. 2017 Nov 22;12(11):e0188490. doi: 10.1371/journal.pone.0188490. https://pubmed.ncbi.nlm.nih.gov/29166672/ [10] Chen VC, Wu SI, Huang KY, et al. Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study. J Clin Psychiatry. 2018 Jan/Feb;79(1):16m11312. doi: 10.4088/JCP.16m11312. https://pubmed.ncbi.nlm.nih.gov/29244265/ [11] Bae S, Yun SC, Kim MC, et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021 Aug;271(5):987-997. doi: 10.1007/s00406-020-01157-4. https://pubmed.ncbi.nlm.nih.gov/32613564/ [12] Shim Y, Park M, Kim J. Increased incidence of dementia following herpesvirus infection in the Korean population. Medicine (Baltimore). 2022 Oct 14;101(41):e31116. doi: 10.1097/MD.0000000000031116. https://pubmed.ncbi.nlm.nih.gov/36254002/ [13] Shin E, Chi SA, Chung TY, et al. The associations of herpes simplex virus and varicella zoster virus infection with dementia: a nationwide retrospective cohort study. Alzheimers Res Ther. 2024 Mar 12;16(1):57. doi: 10.1186/s13195-024-01418-7. https://pubmed.ncbi.nlm.nih.gov/38475873/ [14] Ukraintseva S, Yashkin AP, Akushevich I, et al. Associations of infections and vaccines with Alzheimer’s disease point to a role of compromised immunity rather than specific pathogen in AD. Exp Gerontol. 2024 Jun 1;190:112411. doi: 10.1016/j.exger.2024.112411. https://pubmed.ncbi.nlm.nih.gov/38548241/ [15] Eckerström M, Nilsson S, Zetterberg H, et al. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study. Sci Rep. 2020 Dec 28;10(1):22400. doi: 10.1038/s41598-020-79800-2. https://pubmed.ncbi.nlm.nih.gov/33372192/ [16] Yeh TS, Curhan GC, Yawn BP, et al. Herpes zoster and long-term risk of subjective cognitive decline. Alzheimers Res Ther. 2024 Aug 14;16(1):180. doi: 10.1186/s13195-024-01511-x. https://pubmed.ncbi.nlm.nih.gov/39138535/ [17] Warren-Gash C, Williamson E, Shiekh SI, et al. No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann Clin Transl Neurol. 2022 Mar;9(3):363-374. doi: 10.1002/acn3.51525. https://pubmed.ncbi.nlm.nih.gov/35170873/ [18] Schmidt SAJ, Veres K, Sørensen HT, et al. Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study. Neurology. 2022 Aug 15;99(7):e660-e668. doi: 10.1212/WNL.0000000000200709. https://pubmed.ncbi.nlm.nih.gov/35676090/ [19] Weinmann S, Rawlings A, Koppolu P, et al. Herpes zoster diagnosis and treatment in relation to incident dementia: A population-based retrospective matched cohort study. PLoS One. 2024 Jan 25;19(1):e0296957. doi: 10.1371/journal.pone.0296957. https://pubmed.ncbi.nlm.nih.gov/38271405/ [20] Lophatananon A, Mekli K, Cant R, et al. Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort. BMJ Open. 2021 Oct 8;11(10):e045871. doi: 10.1136/bmjopen-2020-045871. https://pubmed.ncbi.nlm.nih.gov/34625411/ [21] Warren-Gash C, Forbes HJ, Williamson E, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019 Mar 18;9(1):4743. doi: 10.1038/s41598-019-41218-w. https://pubmed.ncbi.nlm.nih.gov/30894595/ [22] Elhalag RH, Motawea KR, Talat NE, et al. Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Oct 27;102(43):e34503. doi: 10.1097/MD.0000000000034503. https://pubmed.ncbi.nlm.nih.gov/37904465/ [23] Zhu L, Hu C, Mei Y, et al. Effect of varicella‐zoster virus infection and antiviral treatment on the risk for dementia: A meta‐analysis of observational studies. Brain Behav. 2024 Feb.5. doi: 10.1002/brb3.3407 https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.3407 [24] Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0. https://pubmed.ncbi.nlm.nih.gov/39096926/ [25] Lehrer S, Rheinstein PH. Herpes Zoster Vaccination Reduces Risk of Dementia. In Vivo. 2021 Nov-Dec;35(6):3271-3275. doi: 10.21873/invivo.12622. https://pubmed.ncbi.nlm.nih.gov/34697158/ [26] Scherrer JF, Salas J, Wiemken TL, et al. Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts. PLoS One. 2021 Nov 17;16(11):e0257405. doi: 10.1371/journal.pone.0257405. https://pubmed.ncbi.nlm.nih.gov/34788293/ [27]Wiemken TL, Salas J, Morley JE, et al. Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations. J Am Geriatr Soc. 2022 Apr;70(4):1157-1168. doi: 10.1111/jgs.17606. https://pubmed.ncbi.nlm.nih.gov/34897645/ [28] Harris K, Ling Y, Bukhbinder AS, et al. The Impact of Routine Vaccinations on Alzheimer’s Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching. J Alzheimers Dis. 2023;95(2):703-718. doi: 10.3233/JAD-221231. https://pubmed.ncbi.nlm.nih.gov/37574727/ [29] Lophatananon A, Carr M, Mcmillan B, et al. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink. BMC Public Health. 2023 Oct 2;23(1):1903. doi: 10.1186/s12889-023-16768-4. https://pubmed.ncbi.nlm.nih.gov/37784088/ [30] Tang E, Ray I, Arnold BF, Acharya NR. Recombinant zoster vaccine and the risk of dementia. Vaccine. 2025 Feb 6;46:126673. doi: 10.1016/j.vaccine.2024.126673. https://pubmed.ncbi.nlm.nih.gov/39733478/ [31] Taquet M, Dercon Q, Todd JA, et al. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024 Oct;30(10):2777-2781. doi: 10.1038/s41591-024-03201-5. Epub 2024 Jul 25. https://pubmed.ncbi.nlm.nih.gov/39053634/ [32] Eyting M, Xie M, Michalik F, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025 Apr 2. doi: 10.1038/s41586-025-08800-x. https://pubmed.ncbi.nlm.nih.gov/40175543/ [33] Pomirchy M, Bommer C, Pradella F, et al. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025 Jun 17;333(23):2083-2092. doi: 10.1001/jama.2025.5013. https://pubmed.ncbi.nlm.nih.gov/40267506/ [34] Polisky V, Littmann M, Triastcyn A, et al. Varicella-zoster virus reactivation and the risk of dementia. Nat Med. 2025 Oct 6. doi: 10.1038/s41591-025-03972-5. Epub ahead of print. https://pubmed.ncbi.nlm.nih.gov/41053450/ [35] Xie M, Eyting M, Bommer C, et al. The effect of shingles vaccination at different stages of the dementia disease course. Cell. 2025 Dec.2. doi: 10.1016/j.cell.2025.11.007. Epub ahead of print. https://pubmed.ncbi.nlm.nih.gov/41338191/ [36] Pomirchy M, Chung S, Bommer C, et al. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026 Feb;25(2):170-180. doi: 10.1016/S1474-4422(25)00455-7. https://pubmed.ncbi.nlm.nih.gov/41579903/[37] Rayens E, Sy LS, Qian L, et al. Recombinant zoster vaccine is associated with a reduced risk of dementia. Nat Commun. 2026 Feb 9. doi: 10.1038/s41467-026-69289-0.
https://pubmed.ncbi.nlm.nih.gov/41663414/
